$47.42-0.94 (-1.94%)
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.
Bio-Techne Corporation in the Healthcare sector is trading at $47.42. The stock is currently near its 52-week low of $45.12, remaining 18.2% below its 200-day moving average. Technical signals show neutral RSI of 33 and bearish MACD signal, explaining why TECH maintains its current current market pressure. The Whystock Score of 35/100 signals elevated caution as indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, ...